237421-20-4

Basic information

• Product Name: [(4-chloro-2-nitro-phenyl)-hydrazono]-(ethoxyoxalyl-amino)-acetic acid ethyl ester
• CAS NO: 237421-20-4
• Molecular Weight: 386.749
• Mol File: 237421-20-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [(4-chloro-2-nitro-phenyl)-hydrazono]-(ethoxyoxalyl-amino)-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [(4-chloro-2-nitro-phenyl)-hydrazono]-(ethoxyoxalyl-amino)-acetic acid ethyl ester(237421-20-4)
• EPA Substance Registry System: [(4-chloro-2-nitro-phenyl)-hydrazono]-(ethoxyoxalyl-amino)-acetic acid ethyl ester(237421-20-4)

Safety Data

• Hazardous Substances Data: 237421-20-4(Hazardous Substances Data)

Upstream product

• 89-63-4 4-Chloro-2-nitroaniline 
• 112091-27-7 C₁₀H₉Cl₂N₃O₄ 
• 114303-80-9 C₁₀H₁₁ClN₄O₄ 
• 4755-77-5 Ethyl oxalyl chloride 

Downstream Products

• 237421-26-0 1-(4-chloro-2-nitro-phenyl)-1H-[1,2,4]triazole-3,5-dicarboxylic acid diethyl ester 

Relevant articles and documents

1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: Synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substitued derivatives

A number of 4-oxo-substituted 1,2,4-triazolo[1,5-a]quinoxaline derivatives bearing at position-2 the claimed (hetero)aryl moiety (compounds 1-15) but also a carboxylate group (16-28, 32-36) or a hydrogen atom (29-31) were designed as human A3 (